Retinoblastoma - Pipeline Review, H1 2014 - New Study Released
therapeutics assessment by drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players
involved in the therapeutic development for Retinoblastoma and special
features on late-stage and discontinued projects.